AngioDynamics, Inc.
corporate_fare Company Profile
AngioDynamics, Inc. (NASDAQ:ANGO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 20 items for ANGO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-14, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for ANGO spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- Humana Medicare Advantage Coverage Expands NanoKnife IRE Access for Prostate and Liver Cancer
- AngioDynamics Plunges 21% Despite Q1 Beat as AngioVac Weakness Spooks Investors
- AngioDynamics Q1 FY2027: Revenue Up 6.9%, Gross Margin Expands 410 bps, Cash Burn Continues
- AngioDynamics Q1 FY2027: Med Tech Growth Accelerates, Guidance Reiterated
- AngioDynamics Names Eric Honroth CEO with $2.3M Signing Package; Clemmer Stays as $30K/Month Consultant
Financial Snapshot
Short Interest & Short Volume
2.92 days to coverFINRA reported short interest of 2,003,326 shares in ANGO as of the October 30, 2026 settlement, a 4.5% increase from the prior period — about 2.9 days to cover at its recent average daily volume. On November 20, 2026, 49.4% of ANGO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.